Recently, microRNAs (miRNAs) have been shown to involve in the process of heart failure. This study aims to investigate the functional role of miR-147b in rat H9c2 cardiomyocytes and explore the underlying molecular mechanisms. Cell viability of H9c2 cells was detected by MTT assay. Cell apoptosis was detected by flow cytometry. Expression of miR-147b and KLF13 mRNA was detected by quantitative real-time PCR. The relationship between miR-147b and KLF13 was verified by dual-luciferase reporter assay. Protein levels were detected by western blot analysis. It was found that H 2 O 2 inhibited cell viability and promoted cell apoptosis of H9c2 cells in a concentration-dependent manner. MiR-147b overexpression suppressed cell viability and increased apoptosis in H9c2 cells, while knock-down of miR-147b increased cell viability and reduced apoptosis in H 2 O 2 -treated H9c2 cells. Luciferase reporter assay and in vitro functional assay showed that KLF13 was a downstream target of miR-147b, and KLF13 knock-down suppressed cell viability and induced apoptosis in H9c2 cells. Enforced expression of KLF13 restored the effects of miR-147b overexpression on cell viability and apoptosis in H9c2 cells. MiR-147b modulated the expression levels of apoptosis-related proteins, and the effects of miR-147b overexpression on apoptosis-related proteins levels were prevented by enforced expression of KLF13 in H9c2 cells. The in vivo experiments showed that miR-147b was up-regulated, and KLF13 was down-regulated in the myocardial tissues from rats with chronic heart failure. Collectively, miR147b inhibits viability and promotes cell apoptosis by targeting KLF13 in H9c2 cells, which may be associated with the pathogenesis of heart failure.
Introduction
Heart disease has the world's highest mortality [1] , and coronary disease and heart failure are particularly serious. Ischemic myocardial infarction is one of the most common causes of heart failure. In recent years, great progress has been made in the treatment of cardiovascular disease, but its morbidity and mortality are still high. There is evidence that oxidative stress injury is the main pathogenesis of various hypoxic-ischemic heart diseases [2] [3] [4] . Reactive oxygen species and oxygen free radicals in the body are generated and cleared under normal circumstances in a dynamic equilibrium state, but in some pathological conditions, reactive oxygen species formation goes faster than body's clearance ability, which will cause tissue cell oxidative stress injury [5] . Studies have shown that during pathogenesis of myocardial ischemia, cardiac remodeling, myocardial ischemia and reperfusion injury, there are usually active oxygen and oxygen free radicals accumulations, and the accumulation of reactive oxygen species can further cause myocardial cell necrosis and apoptosis, which ends with an increase in disease severity [6] . Cell necrosis generally occurs in the final stage of myocardial ischemia or ischemia-reperfusion injury, but the apoptosis of cardiomyocytes often runs through the entire course of the disease [7, 8] . Therefore, it is very important to improve therapeutic effect of cardiovascular disease and cardiac function by reducing oxidative stress injury and apoptosis in cardiomyocytes.
Recently, basic and clinical studies have shown that microRNAs (miRNAs) can regulate the gene expression via targeting the 3′ untranslated region (3′UTR) of the specific genes, and they have been reported to play a significant role in cell differentiation, growth, proliferation, and apoptosis [9, 10] . Studies have shown that miR-147b could significantly promote ovarian cancer cell apoptosis and inhibit proliferation [11] . Studies also showed that expression of miR-147b triggered by lipopolysaccharides and hypoxia exhibits cellular effects (i.e. cell proliferation, migration, and apoptosis in cancer cells) similar to that of miR-210 [12] . In addition, miR-210 has been identified as a biomarker for the cardiovascular diseases, particularly, heart failure [13] . Therefore, we hypothesize that miR147b may have similar functions in cardiomyocytes and may be a new biomarker for early diagnosis, treatment and prognosis of heart failure disease.
In this study, we used hydrogen peroxide (H 2 O 2 ) to treat rat H9c2 cells (a cardiomyocyte cell line), which simulated the cell model of heart failure caused by oxidative stress injury. The relative expression of miR-147b in H9c2 cells was determined by quantitative real-time PCR (qRT-PCR). The in vitro functional roles of miR147b in cell viability and cell apoptosis of H9c2 cells were examined by the MTT assay and cell apoptosis assay. Furthermore, the Kruppel-like factor 13 (KLF13), a downstream target of miR-147b predicted by bioinformatics analysis, was also investigated by a series of in vitro functional assays. Finally, the expression levels of miR-147b and KLF13 in rat model of chronic heart failure (CHF) following myocardial infarction were also explored.
Materials and Methods

Cell culture
Rat H9c2 cardiomyocyte cell line was purchased from the Cell Bank of the Chinese Academy of Sciences, Shanghai Institutes for Biological Sciences (Shanghai, China). The cells were grown in Dulbecco's modified Eagle's medium (DMEM; Thermo Fisher Scientific, Waltham, USA) supplemented with 10% fetal bovine serum (FBS; Thermo Fisher Scientific). The cells were maintained in a humidified atmosphere with 5% CO 2 at 37°C.
MTT assay
Cell viability was determined by using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT; Sigma, St Louis, USA) colorimetric assay. Briefly, cells were seeded in 96-well plates and incubated for 24 h, and cells were subject to different treatment regimens. After the treatments, cells were washed with phosphatebuffered saline (PBS) and then incubated in MTT solution (Sigma) for 3 h. After dimethyl sulfoxide was added into each well, the absorbance was measured at 490 nm to determine the cell viability with a microplate reader (BioTek, Winooski, USA).
Flow cytometry
The cell apoptosis of H9c2 cells was determined using FITC Annexin V and propidium iodide (PI) double staining kit (Invitrogen, Carlsbad, USA). After different treatments, cells were collected and re-suspended, and then incubated with 5 μl of Annexin V and 5 μl of PI. After incubation for 20 min in the dark at room temperature, the cells were stained for 15 min, and flow cytometer (BD Biosciences, San Jose, USA) was used to detect apoptosis. The final test data were analyzed using Flowjo software (Flowjo, Ashland, USA).
Quantitative real-time PCR
Total RNA was extracted from cardiomyocytes or myocardial tissues by using the TRIzol Reagent (Invitrogen). For the analysis of miR-147b expression, an ABI miRNA reverse transcription kit (Applied Biosystems, Foster City, USA) was used to transcribe RNA into cDNA. For the analysis of mRNA expression, the TaqMan Reverse Transcript Kit (Thermo Fisher Scientific) was used to transcribe RNA into cDNA. PCR was performed by suing a Power SYBR green kit (Thermo Fisher Scientific) on an ABI 7500 RealTime PCR System (Applied Biosystems). U6 was used as an internal control for miRNA expression, and GAPDH was used as an internal control for mRNA expression. The relative expression levels of miR-147b and KLF13 mRNA were calculated by 2 −ΔΔCt method.
Primer sequences were shown in Table 1 .
Cell transfection
Cells were seeded in 96-well plates at a density of 1 × 10 4 cells/well.
When cell density reached~80%, the culture medium was replaced by a serum-free medium. All the oligonucleotides including miR147b mimic, mimic NC, miR-147b inhibitor, inhibitor NC, KLF13 siRNA, and siRNA NC (GenePharma, Shanghai, China) were transfected into H9c2 cells by using the Lipofectamine 2000 reagent (Invitrogen) according to the manufacturer's instructions. At 24 h post-transfection, fresh medium was replaced for subsequent experiments. The specific treatment groups were shown in Table 2 .
Dual-luciferase reporter assay
The mutant 3′UTR of KLF13 was generated by using the QuickChange Site-Directed Mutagenesis kit (Stratagene, Lo Jolla, USA). The 3′UTR of KLF13 harboring either the miR-147b binding site or the mutant 3′UTR of KLF13 was cloned into the psiCHECK-2 vector (Promega, Madison, USA) to generate the psiCHECK-KLF13 3′ UTR luciferase reporter plasmid. Luciferase reporter plasmid and miR-147b mimic or miR-147b inhibitor were co-transfected into H9c2 cells by using Lipofectamine 2000 reagent in accordance with the manufacturer's instruction. At 48 h after transfection, a dual luciferase reporter gene assay kit (Promega) was used to determine the luciferase activities, and renilla luciferase activity was normalized to firefly luciferase activity.
Western blot analysis
After different treatments, proteins from H9c2 cells were extracted by using RIPA lysis buffer (Sigma, St Louis, USA). The protein concentration was quantified and 30 μg of total proteins were separated by 10% SDS-PAGE and then transferred to the PVDF membrane. After being blocked with 5% skimmed milk at room temperature for 1 h, membranes were incubated with the primary antibodies at 4°C overnight. The primary antibodies were all from Abcam (Cambridge, USA), including rabbit anti-KLF13 antibody (1:1000), rabbit anticaspase-3 antibody (1:1500), rabbit anti-caspase-9 antibody (1:1000), rabbit anti-Bax antibody (1:1500), rabbit anti-Bcl-2 antibody (1:2000), and rabbit anti-β-actin antibody (1:3000). After extensive wash, membranes were incubated with the corresponding HRP-conjugated secondary antibody (Cell Signaling Technology, Danvers, USA) at room temperature for 1 h. Finally, the protein bands were visualized by using the ECL substrate kit (Thermo Fisher Scientific).
Animal model of CHF
Male Sprague-Dawley rats used in the in vivo experiments were purchased from The Animal Center of Nanjing Medical University (Nanjing, China). All the animal experiments were approved by the Animal Ethics Committee of Nanjing Central Hospital. The CHF model of rat was established by coronary artery ligation as previously reported [14] . Briefly, rats were anesthetized with pentobarbital sodium (40 mg/kg, i.p.), and a left thoracotomy was performed via the fifth intercostal space. After the lung was retracted, the pericardium was opened to expose the heart, and the left coronary artery was ligated using a 6-0 suture near its brain point from the aorta, between the pulmonary aorta outflow tract and left atrium. After the gas was discharged in the chest, the muscle layer and skin was closed by using a 5-0 suture. For the sham-operated rats, the same procedure was employed except that the artery was not ligated. After surgery, the rats were given penicillin for 3 days to prevent infection. The left ventricular ejection fraction (LVEF) was reduced by 45%, as revealed by ultrasonic cardiogram, indicating the successful establishment of the CHF rat model. At 8 weeks postsurgery, after transthoracic echocardiography, the myocardial tissues were collected for further analysis.
Echocardiographic measurements
Transthoracic echocardiography was performed at the end of 
Statistical analysis
All data were analyzed by Graphpad Version 6.0 software. All the experiments were repeated at least three times for each group. Data were expressed as the mean ± SEM. The t test was used for comparisons between two groups. One-way analysis of variance followed by Bonferroni post-hoc test was applied for comparisons among multiple groups. P < 0.05 was considered to be statistically significant.
Results
Effects of H 2 O 2 on cell viability, cell apoptosis, and miR-147b expression in rat H9c2 cells
The H9c2 cells were treated with different concentrations of H 2 O 2 (50-200 μM), and cell viabilities, cell apoptosis and the expression of miR-147b were determined by MTT, flow cytometry, and qRT-PCR, respectively. As shown in Fig. 1A , cell viability was significantly lower in the H 2 O 2 -treated groups than in the 0 μM treatment group, and the effect was in a concentration-dependent manner.
Results of the flow cytometry for detection of apoptosis were shown in Fig. 1B . The apoptotic rates were significantly increased after H 2 O 2 treatment compared with the 0 μM treatment group, and the effect was in a concentration-dependent manner. The expression of miR-147b in H9c2 cells treated with H 2 O 2 was measured by qRT-PCR. As shown in Fig. 1C , the expression levels of miR-147b were significantly up-regulated after treatment with H 2 O 2 at all concentrations compared to the 0 μM treatment group, and reaching the maximum at 150 μM of H 2 O 2 . Therefore, 150 μM of H 2 O 2 was used in the subsequent experiments. Effects of miR-147b on cell viability and apoptosis in H9c2 cells
As shown in Fig. 2A , the expression of miR-147b was significantly increased after transfection with miR-147b mimic in H9c2 cells, and the expression of miR-147b was significantly decreased after miR147b inhibitor was transfected into H9c2 cells ( Fig. 2A) . After transfection with miR-147b mimic, the cell viability of H9c2 cells was significantly lower than that of the negative control group (Fig. 2B) , while the apoptotic rate in the miR-147b mimic group was significantly higher than that in the negative control group (Fig. 2C) .
Further MTT and flow cytometry results showed that transfection with miR-147b inhibitor could reverse the cell viability inhibition and cell apoptosis promotion induced by H 2 O 2 in H9c2 cells (Fig. 2D,E) . . n = 3. Significant differences between treatment groups were indicated as *P < 0.05, **P < 0.01, ***P < 0.001.
KLF13 was a potential target of miR-147b
Based on the bioinformatics analysis using the online software TargetScan (http://www.targetscan.org), KLF13 was found to be a target gene of miR-147b, and the miR-147b-targeted 3′UTR of KLF13 was conserved among multiple species (Fig. 3A) . The luciferase reporter vectors which contain the KLF13 3′UTR fragments with wild-type (psi-CHECK2-KLF13-3′UTR) or mutant (psi-CHECK2-KLF13-3′UTR mut) miR-147b complementary sites were shown in Fig. 3A . As shown in Fig. 3B , with the luciferase reporter containing wild-type KLF13 3′UTR, transfection with miR-147b mimic resulted in a significant reduction in luciferase activity compared with mimic NC group in H9c2 cells, while transfection with miR147b inhibitor increased the luciferase activity compared with inhibitor NC in H9c2 cells (Fig. 3B) . In addition, with the luciferase reporter containing a mutated segment of KLF13 3′UTR, miR-147b mimic or miR-147b inhibitor transfection had no effect on the luciferase activity when compared with their respective negative controls in H9c2 cells (Fig. 3C) . The expression of KLF13 mRNA and protein was detected by qRT-PCR and western blot analysis, and the results showed that the expression levels of KLF13 mRNA and protein in the miR-147b mimic group were significantly lower than those of the mimic NC group, while the expression levels of KLF13 mRNA and proteins were significantly higher in miR-147b inhibitor group than those of the inhibitor NC group (Fig. 3D,E) .
Effects of KLF13 knock-down on cell viability, cell apoptosis in H9c2 cells
The expression of KLF13 mRNA and protein was detected by qRT-PCR and western blot analysis after transfection with KLF13 siRNA. The results showed that KLF13 siRNA transfection significantly decreased the mRNA and protein expression of KLF13 (Fig. 4A,B) . Furthermore, MTT assay and flow cytometry were used to detect cell viability and apoptosis of H9c2 cells transfected with KLF13 siRNA, and the results showed that after KLF13 siRNA transfection, cell apoptosis was significantly increased and cell viability was significantly decreased (Fig. 4C,  D) . Co-transfection of miR-147b mimic and KLF13 overexpression plasmid significantly reversed cell viability inhibition and apoptotic rate promotion induced by miR-147b mimic transfection (Fig. 4E,F) . could promote cell apoptosis, while miR-147b inhibitor transfection could reverse this effect in H9c2 cells. n = 3. Significant differences between treatment groups were indicated as *P < 0.05, **P < 0.01, ***P < 0.001.
Effects of miR-147b on the levels of cell apoptosisrelated proteins in H9c2 cells
To further explore the role of miR-147b in the apoptosis of H9c2 cells, western blot analysis was performed to determine the expressions of caspase-3, caspase-9, Bax, and Bcl-2. MiR-147b mimic transfection significantly increased the expressions of caspase-3, caspase-9, and Bax, and decreased the expression of Bcl-2 (Fig. 5A) . Furthermore, the expressions of caspase-3, caspase-9, and Bax were significantly increased in the H 2 O 2 -treated H9c2 cells, while Bcl-2 expression was inhibited in the H 2 O 2 -treated H9c2 cells (Fig. 5B) . MiR-147b inhibitor transfection significantly decreased the expressions of caspase-3, caspase-9, and Bax in H 2 O 2 -treated cells, but increased Bcl-2 expression in H 2 O 2 -treated cells (Fig. 5B) . Co-transfection of miR-147b mimic and KLF13 overexpression plasmid significantly reversed the changes in expression levels of apoptosis-related proteins induced by miR-147b mimic transfection (Fig. 5C) .
Effects of myocardial infarction on the expression of miR-147b and KLF13 in rat myocardial tissues
In the in vivo experiments, we established a rat model of CHF following myocardial infarction, and the echocardiographic measurements from sham-operated rats and CHF rats were shown in Table 3 . The expressions of miR-147b and KLF13 in the rat myocardial tissues were determined by qRT-PCR, and the results showed that the expression of miR-147b in the myocardial tissues from CHF rats was significantly up-regulated, while the expression of KLF13 mRNA in the myocardial tissues from CHF rats was significantly down-regulated when compared to those from sham-operated rats (Fig. 6A,B) .
Discussion
At present, thrombolysis, percutaneous coronary intervention, coronary artery bypass grafting, and other methods are widely used in the treatment of ischemic heart disease, especially acute myocardial infarction, which saves some of the dying cardiomyocytes and protects myocardium to a certain extent, but myocardial apoptosis still cannot be avoided, and thus exploring the underlying mechanisms of apoptosis during myocardial injury is necessary for clinical provision of targeting therapy. Classical apoptotic pathway is mediated by caspase under specific stimuli, and Bcl-2 protein family plays an important regulatory Western blot analysis results showed that miR147b mimic transfection could significantly down-regulate KLF13 protein expression and miR-147b inhibitor transfection could significantly up-regulate KLF13 protein expression in H9c2 cells. n = 3. Significant differences between treatment groups were indicated as *P < 0.05, **P < 0.01. role in this process [15] [16] [17] . Recently, it has been found that miRNAs play a very important role in the development of cardiovascular disease by regulating heart development, differentiation, proliferation, apoptosis, metabolism, and other aspects of cardiovascular system [18] . However, how to maintain stable expression of specific miRNAs in cardiovascular system is still an important question that may provide a new strategy for targeted therapies of cardiovascular and other diseases. In this study, H 2 O 2 was used to treat H9c2 cells. H 2 O 2 was able to inhibit cardiomyocyte viability in a dose-dependent manner, and further apoptosis detection by flow cytometry revealed that H 2 O 2 triggered the activation of apoptosis. Meanwhile, miR-147b expression was detected by qRT-PCR, and the results showed that H 2 O 2 could up-regulate the expression of miR-147b in H9c2 cells. These results suggest that miR-147b may be involved in the process of oxidative stress injury and cell apoptosis induced by H 2 O 2 .
Up to date, several studies have found that cardiomyocyte apoptosis is closely related to myocardial infarction. In the study of ischemia-reperfusion injury [19] , overexpression of Bcl-2 protein was found to decrease the infarct size, apoptosis, and function injuries of cardiomyocytes [20] . These results suggested that apoptosis played a very important regulatory role in myocardial infarction. Therefore, suppressing apoptosis is important for reducing myocardial infarct size. A large number of studies showed that miRNAs were not only restricted to their roles in tumor cells, but also involved in the regulation of cellular functions of cardiomyocytes. It was found that miR-1 played an important role in apoptosis regulation of cardiomyocytes [21, 22] . The expression of miR-1 was significantly upregulated in oxidative stress-treated H9c2 cells. In addition, in a study of ischemia-reperfusion injury rat model, miR-1 was found to be able to target the anti-apoptotic protein, Bcl-2 [20] . MiR-1 may affect cardiomyocyte apoptosis by post-transcriptional regulation of Bcl-2 protein [23] . It was also found that miR-320 was up-regulated in ischemic heart and its target gene was heat shock protein 20 which is a known cardioprotective protein, and knock-down of miR-320 could reduce myocardial ischemia-induced apoptosis and necrosis [23] . Studies in ovarian cancer showed that up-regulation of miR-147b promoted apoptosis via activation of caspase-dependent death signaling [11] . In addition, miR-147b overexpression was also reported to induce apoptosis in lung adenocarcinoma A549 cells [12] . We found that miR-147b mimic transfection significantly increased the expression of miR-147b in H9c2 cells, whereas high expression of miR147b inhibited H9c2 cell viability, promoted apoptosis, inhibited Bcl-2 protein expression, and promoted caspase-3/caspase-9/Bax protein expression, while suppression of miR-147b reversed cell viability inhibition and cell apoptosis promotion induced by H 2 O 2 in H9c2 cells, suggesting an important role of miR-147b in the regulation of cell viability and cell apoptosis in H9c2 cells.
In the present study, the bioinformatics analysis and luciferase reporter assay revealed that KLF13 is a potential downstream target of miR-147b. KLF13 belongs to the KLF family and is a zinc-finger DNA binding transcription factors homologous to Drosophila gap gene Kruppel [24] . Studies have suggested that KLF13 may involve in the regulation of various cellular processes including cardiac biology [24] . Recently, KLF13 has been shown to prevent cardiomyocyte DNA damage and reduce apoptosis [24, 25] . Our results revealed that when the KLF13 expression was down-regulated, the cell viability was significantly decreased and the apoptotic rate was significantly increased in H9c2 cells, and enforced expression of KLF13 in H9c2 cells reversed the effects of miR-147b overexpression on cell viability, cell apoptotic rate, and expressions of apoptosis-related proteins in H9c2 cells. Collectively, these results suggested that the regulatory role of miR-147b in H9c2 cells might be mediated via targeting KLF13. Among the KLF family members, KLF4 has been well-documented for its important role in cardiac hypertrophy [26, 27] , and KLF15 also plays a key role in heart disease. However, based on the bioinformatics analysis, KLF4 and KLF15 are not the potential targets of miR1-47b, thus, the effects of miR-147b on KLF4 and KLF15 were not explored in the study [28] . As miR-147b may have other potential downstream targets which have not been examined in the present study, future studies are required to confirm the interaction between miR-147 and other downstream targets of miR-147b.
Compared with primary rat cardiomyocytes, H9c2 cell line has its own limitations, and our observations cannot be fully extrapolated to the in vivo environment. Therefore, we further performed in vivo experiments in the rat model of CHF following myocardial infarction. The results showed that the expression of miR-147b was significantly up-regulated, while the expression of KLF13 was significantly down-regulated in the myocardial tissues from CHF rats, Figure 4 . Effects of KLF13 knock-down on cell viability, cell apoptosis in H9c2 cells KLF13 siRNA transfection could significantly decrease KLF13 mRNA expression (A), protein expression (B) and cell viability (C), but increase cell apoptotic rate (D). KLF13 overexpression could significantly prevent the inhibitory effect of miR-147b overexpression on (E) cell viability and (F) apoptosis in rat cardiomyocytes. n = 3. Significant differences between treatment groups were indicated as *P < 0.05, **P < 0.01.
suggesting the potential roles of miR-147b and KLF13 in the regulation of heart failure. Indeed, miRNAs have been shown to be involved in the regulation of the CHF in the rats. For instance, miR-31 was up-regulated in the myocardial tissues from rats with myocardial infarction, and inhibition of miR-31 alleviated the myocardial infarction-induced symptoms [29] . MiR-1231 was found to exacerbate arrhythmia by inhibiting cacna2d2 in ischemic heart of the rats [30] . In addition, studies also showed that miR133a improved the cardiac function through inhibiting Akt in the rats with heart failure [14] . To better confirm the in vivo regulatory of miR-147b in heart failure, further in vivo experiments should be performed to determine the effects of miR-147b overexpression/ down-regulation on the cardiac function in the rats with heart failure.
In summary, our results suggest that miR-147b inhibits cell viability and promotes cell apoptosis by targeting KLF13 in H9c2 cells, which may be associated with the pathogenesis of heart failure. However, the in vivo function of miR-147b should be further Figure 5 . Effects of miR-147b on cell apoptosis-related protein levels in H9c2 cells (A) Western blot analysis results showed that miR-147b mimic transfection could promote pro-apoptotic protein expression and inhibit anti-apoptotic protein expression. (B) Western blot analysis results showed that miR-147b inhibitor transfection could reverse the effect of H 2 O 2 on apoptotic-related protein expression. (C) Western blot analysis results showed that enforced expression of KLF13 could reverse the effect of miR-147b on apoptotic-related protein expression. n = 3. Significant differences between treatment groups were indicated as *P < 0.05, **P < 0.01. investigated to determine the regulatory role of miR-147b in heart failure. 3.14 ± 0.13 2.33 ± 0.14** SI 1.95 ± 0.13 1.26 ± 0.09*** FS (%) 40.6 ± 3.4 23.7 ± 6.7* EF (%) 83.4 ± 7.9 53.2 ± 11.2* LVEDD, left ventricular end-diastolic diameter; LVESD, left ventricular end-systolic diameter; LVEDV, left ventricular end-diastolic volume; LVESV, left ventricular end-systolic volume; IVSd, interventricular septal thickness in diastole; IVSs, interventricular septal thickness in systole; LVPWd, left ventricular posterior wall thickness in diastole; LVPWs, left ventricular posterior wall thickness in systole; SI, sphericity index; FS, fractional shortening; EF, ejection fraction. Significant differences between treatment groups were indicated as *P < 0.05, **P < 0.01, ***P < 0.001. Figure 6 . Expression levels of miR-147b and KLF13 in myocardial tissues of sham-operated rats and CHF rats (A) qRT-PCR results showed that miR147b was up-regulated in myocardial tissues in CHF rats compared with sham-operated rats. (B) qRT-PCR results showed that KLF13 was downregulated in myocardial tissues in CHF rats compared with sham-operated rats. n = 7. Significant differences between treatment groups were indicated as ***P < 0.001.
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